We have previously described a C-terminally truncated variant of the chemokine neutrophil-activating peptide 2 (NAP-2) that exhibited higher neutrophil-stimulating capacity than the full-size polypeptide. To investigate the impact of the NAP-2 C terminus on biological activity and receptor binding, we have now purified the novel molecule to homogeneity. Furthermore, we have cloned, expressed in Escherichia coli, and purified full-size recombinant NAP-2 (rNAP-2-(1-70)) and a series of C-terminally deleted variants (rNAP-2-(1-69) to rNAP-2-(1-64)). Biochemical and immunochemical analyses revealed that the natural NAP-2 variant was structurally identical to the rNAP-2-(1-66) isoform. As compared with their respective native and recombinant full-size counterparts, both molecules exhibited 3-4-fold enhanced potency in the induction of neutrophil degranulation as well as 3-fold enhanced binding affinity for specific receptors on these cells. All other variants were considerably less active. The natural occurrence of a NAP-2 variant truncated by exactly four residues at the C terminus suggests that limited and defined proteolysis at this site plays a role in the regulation of the biological function of the chemokine.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				L. Hasan, L. Mazzucchelli, M. Liebi, M. Lis, R. E. Hunger, A. Tester, C. M. Overall, and M. Wolf Function of Liver Activation-Regulated Chemokine/CC Chemokine Ligand 20 Is Differently Affected by Cathepsin B and Cathepsin D Processing. J. Immunol., June 1, 2006; 176(11): 6512 - 6522. [Abstract] [Full Text] [PDF]

				J. E. Ehlert, C. A. Addison, M. D. Burdick, S. L. Kunkel, and R. M. Strieter Identification and Partial Characterization of a Variant of Human CXCR3 Generated by Posttranscriptional Exon Skipping J. Immunol., November 15, 2004; 173(10): 6234 - 6240. [Abstract] [Full Text] [PDF]

				H. J.J.M. Rennen, C. Frielink, E. Brandt, S. A.J. Zaat, O. C. Boerman, W. J.G. Oyen, and F. H.M. Corstens Relationship Between Neutrophil-Binding Affinity and Suitability for Infection Imaging: Comparison of 99mTc-Labeled NAP-2 (CXCL-7) and 3 C-Terminally Truncated Isoforms J. Nucl. Med., July 1, 2004; 45(7): 1217 - 1223. [Abstract] [Full Text] [PDF]

				P. J. Hensbergen, D. Verzijl, C. I. A. Balog, R. Dijkman, R. C. van der Schors, E. M. H. van der Raaij-Helmer, M. J. A. van der Plas, R. Leurs, A. M. Deelder, M. J. Smit, et al. Furin Is a Chemokine-modifying Enzyme: IN VITRO AND IN VIVO PROCESSING OF CXCL10 GENERATES A C-TERMINALLY TRUNCATED CHEMOKINE RETAINING FULL ACTIVITY J. Biol. Chem., April 2, 2004; 279(14): 13402 - 13411. [Abstract] [Full Text] [PDF]

				M. De La Luz Sierra, F. Yang, M. Narazaki, O. Salvucci, D. Davis, R. Yarchoan, H. H. Zhang, H. Fales, and G. Tosato Differential processing of stromal-derived factor-1{alpha} and stromal-derived factor-1{beta} explains functional diversity Blood, April 1, 2004; 103(7): 2452 - 2459. [Abstract] [Full Text] [PDF]

				A. Wuyts, A. D'Haese, V. Cremers, P. Menten, J.-P. Lenaerts, A. De Loof, H. Heremans, P. Proost, and J. Van Damme NH2- and COOH-Terminal Truncations of Murine Granulocyte Chemotactic Protein-2 Augment the In Vitro and In Vivo Neutrophil Chemotactic Potency J. Immunol., December 1, 1999; 163(11): 6155 - 6163. [Abstract] [Full Text] [PDF]

				J. E. Ehlert, J. Gerdes, H.-D. Flad, and E. Brandt Novel C-Terminally Truncated Isoforms of the CXC Chemokine {beta}-Thromboglobulin and Their Impact on Neutrophil Functions J. Immunol., November 1, 1998; 161(9): 4975 - 4982. [Abstract] [Full Text] [PDF]

				A. Ludwig, F. Petersen, S. Zahn, O. Gotze, J.-M. Schroder, H.-D. Flad, and E. Brandt The CXC-Chemokine Neutrophil-Activating Peptide-2 Induces Two Distinct Optima of Neutrophil Chemotaxis by Differential Interaction With Interleukin-8 Receptors CXCR-1 and CXCR-2 Blood, December 1, 1997; 90(11): 4588 - 4597. [Abstract] [Full Text] [PDF]